Home/ Supplements/ Electrolytes/ Magnesium Malate 1250 mg

Magnesium Malate 1250 mg

product on market Tablet or Pill BIOVEA Safety: 92/100
92/100

This product looks safe

  • Magnesium: 425mg is 1.2× the Tolerable Upper Intake Level (350mg)
  • 20% of ingredients have research evidence
C Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

Magnesium malate combines magnesium with malic acid to support muscle function and energy production. Research provides moderate evidence for its role in reducing fatigue and managing fibromyalgia symptoms. The ingredient profile is generally considered safe for most users.

AI-generated summary based on research evidence. Not medical advice.

Alerts

Safety Alerts

Magnesium: 425mg is 1.2× the Tolerable Upper Intake Level (350mg)

Label

Product Label

Label for Magnesium Malate 1250 mg
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Vegetarian Tablet(s)
Serving Size
60
Servings
Non-Nutrient/Non-Botanical
Product Type
20%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Calories
10 {Calories}
Total Carbohydrates
3 Gram(s) (1% DV)
425 mg (106% DV)
Exceeds UL by 1.2× (UL: 350 mg) 316 studies (A:8, B:159)
Sodium
5 mg (1% DV)
Malic Acid
2.5 Gram(s)

Other Ingredients

Stearic Acid Acacia modified Cellulose Gum Silicon Dioxide, Colloidal Magnesium Stearate
Claims

Label Claims — Verification

Unverified All Other
Info

Product Information

Directions for Use

Suggested Daily Intake: Take 1-3 tablets with a meal.

Warnings & Precautions

Warning: If you are pregnant or lactating, consult a health care professional before using this product.

KEEP OUT OF REACH OF CHILDREN.

Do not use this product if the safety seal on the bottle is broken.

Formulation Notes

Note: One (1) 1250mg tablet of Magnesium Malate provides 11.3% pure elemental magnesium and 61.2% malic acid.

Vegetarian Product

Additional Information

guaranteed premium quality

mineral

Store in a cool, dry place.

MADE IN THE USA

GMP COMPLIANT

Metadata

Product Details

UPC / SKU6 89076 04477 6
DSLD Entry Date2015-05-22
Product TypeNon-Nutrient/Non-Botanical
FormTablet or Pill
BrandBIOVEA
DSLD ID45644
Data Updated2026-04-11
Research

Research Evidence

849
Research Sources
56
Avg Quality
450
Meta Analysis
152
Rct
137
Systematic Review
73
Clinical Trial
11
Regulatory Source
7
Other
7
Guideline
3
Openfda Safety
2
Cochrane Review
2
Observational
A Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2015 PubMed DOI
A Vitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people in mid and late life
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems
Meta Analysis The Cochrane database of systematic reviews 2025 PubMed DOI
A Dietary calcium supplementation for preventing colorectal cancer and adenomatous polyps
Systematic Review The Cochrane database of systematic reviews 2008 PubMed DOI
A Calcium and vitamin D for increasing bone mineral density in premenopausal women
Systematic Review The Cochrane database of systematic reviews 2023 PubMed DOI
A Dietary sodium, sodium-to-potassium ratio, and risk of stroke: A systematic review and nonlinear dose-response meta-analysis
Meta Analysis Clinical nutrition (Edinburgh, Scotland) 2019 PubMed DOI
A The association between circulating magnesium and clinically relevant outcomes in patients with chronic kidney disease: A systematic review and meta-analysis
Meta Analysis Clinical nutrition (Edinburgh, Scotland) 2021 PubMed DOI
A Calcium channel blockers versus other classes of drugs for hypertension
Systematic Review The Cochrane database of systematic reviews 2021 PubMed DOI
View all evidence for Electrolytes →
Compare

Similar Products

View all Electrolytes products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.